Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Jefferies Upgrades Disney (NYSE: DIS) to Buy, Sees Operating Income Recovery After Years of Stagnation

Jefferies has upgradedWalt Disney Co. (NYSE: DIS)fromHoldtoBuy, signaling a shift in sentiment as the entertainment conglomerate begins showing signs of operating income growth for the first time in nearly a decade. The firm also raised its price target on Disney stock to USD144, significantly …

Team Kalkine | 30 June 2025

Stocks Rally on Trade Optimism, Rate Cut Hopes, and Easing Geopolitical Tensions

Market Movers:On Friday, the top gainers were Locafy Limited (+225.49%), followed by Blue Gold Limited (+210.79%). On the contrary CID HoldCo, Inc (-47.23%) Liminatus Pharma, Inc (- 42.89%) declined the most the same day.

Team Kalkine | 30 June 2025

Goldman Sachs Upgrades Affiliated Managers Group (NYSE: AMG) to Buy, Sets USD 218 Price Target

Goldman Sachs on Thursday upgraded shares of Affiliated Managers Group, Inc. (NYSE: AMG) fromNeutraltoBuy, assigning a price target of USD218.00. The new target suggests an approximate 17% upside from AMG’s current trading levels near USD199.52, which sits close to the stock’s 52-week high.

Team Kalkine | 30 June 2025

Wall Street Zen Upgrades British American Tobacco (NYSE:BTI) to Buy Amid Mixed Analyst Sentiment

Shares of British American Tobacco plc (NYSE:BTI)received an upgrade from Wall Street Zen over the weekend, with the firm lifting its rating from “Hold” to “Buy,” according to a research note issued on Saturday. This adjustment follows a series of recent analyst updates that …

Team Kalkine | 30 June 2025

Autolus Therapeutics (NASDAQ:AUTL) Reports 55.4% Estimated 3-Year Overall Survival in FELIX Trial of Obe-cel

Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company focused on programmed T cell therapies, has announced updated results from its ongoing FELIX trial evaluating obe-cel, an autologous CD19 CAR T-cell therapy, in adults with relapsed or refractory (r/r) CD19-positive B-cell acute lymphoblastic leukemia (B-ALL).

Team Kalkine | 30 June 2025

Lemonade (NYSE: LMND) Achieves USD 1B IFP, Grows Revenue by 27% in Q1

Lemonade Inc. (NYSE: LMND)is a U.S.- and Europe-based insurer offering renters, homeowners, auto, pet, and life insurance through multiple sales channels.

Team Kalkine | 28 June 2025

Global Markets Rally on Trade Deals, Fed Rate Cut Hopes, and Geopolitical Easing

Index Update:S&P 500 and Nasdaq 100 futures pointed to record-high openings, with the Dow set to rise by 150 points, driven by optimism over a new U.S.–China trade agreement that eases tariffs and secures rare earth supplies. Additional progress with India and the removal …

Team Kalkine | 27 June 2025

Sanford C. Bernstein Initiates Coverage on ASML (NASDAQ: ASML) with “Market Perform” Rating, Sets USD 806 Target

ASML Holding N.V. (NASDAQ: ASML), a key supplier of lithography equipment for the semiconductor industry, has been the focus of multiple research reports, reflecting a spectrum of views on the company’s valuation and growth outlook. In the latest update, Sanford C. Bernstein initiated coverage …

Team Kalkine | 27 June 2025

BMO Capital Markets Lifts FactSet (NYSE: FDS) Price Target to USD 452; Maintains “Market Perform” Rating

FactSet Research Systems (NYSE: FDS) has continued to draw varied analyst opinions, with BMO Capital Markets the latest to adjust its valuation outlook on the financial data and analytics provider. In a research report released on June 20th, BMO raised its price objective for …

Team Kalkine | 27 June 2025

Li Auto (Nasdaq: LI; HKEX: 2015) Cuts Q2 2025 Delivery Outlook to 108,000 Vehicles Amid Sales System Upgrade

Li Auto Inc. (Nasdaq: LI; HKEX: 2015)announced a downward revision to its vehicle delivery guidance for the second quarter of 2025, citing transitional impacts from ongoing upgrades to its sales infrastructure. The company now anticipates delivering roughly 108,000 vehicles in the quarter, below its …

Team Kalkine | 27 June 2025
Support

Hi! How can we help you today?

Loading…